Join Rheaply CEO Dr. Garry Cooper, Jr. to learn about his experience as a scientist turned tech CEO, and how his background in neuroscience powers Rheaply's vision today to scale the circular economy with technology. Dr. Cooper will walk through the strategies and challenges of running a venture-backed company in Chicago, and the opportunities for others considering a similar jump in their career.
Assistant Director, Career Advancement
Helen oversees the digital programs including the NAA Career Webinar Series along with the NAA Career Podcast, Northwestern Intersections, to provide career advancement resources for the alumni network. She is passionate about engaging alumni to share their stories of how Northwestern has impacted their lives.
Dr. Garry Cooper '15 PhD
Dr. Garry Cooper is the CEO/Co-founder of Rheaply, Inc. Dr. Cooper is also a Scholar at Google for Entrepreneurs and an Adj. Assistant Professor at Northwestern University’s Department of Physiology. Before Rheaply, Inc., Dr. Cooper was a Senior Consultant at Ernst & Young, LLP in the Life Science Advisory practice where he worked in performance improvement and supply chain for pharmaceutical clients. Before joining Ernst & Young and his current position in the physiology department at the Feinberg School of Medicine and X, Dr. Cooper was a postdoctoral fellow at Northwestern University in the department of physiology at the Feinberg School of Medicine, where he worked with Profs. Richard Silverman, Eric Weiss, and D. James Surmeier in furthering efforts to develop and identify a therapeutic measure to slow the progression of Parkinson’s disease. Before his postdoctoral training, Dr. Cooper was a consultant at Promidian Consulting, a NY-based pharmaceutical consulting firm. In Promidian’s Chicago office, Dr. Cooper worked on projects concerning late-stage clinical trial/pre-market launch strategy. Before joining Promidian, Dr. Cooper worked on drug development for Parkinson’s disease at Northwestern University. Much of this work was done while completing his PhD in neuroscience at Northwestern University under the supervision of Richard B. Silverman (inventor of Lyrica®) and D. James Surmeier. While at Northwestern University, Dr. Cooper received several awards for scientific merit and presentation, published in high-impacting peer-reviewed international journals (i.e., Nature Communication), and participated in a drug development effort that led to a US patent. Before coming to Northwestern, Dr. Cooper worked in the department of chemistry at Indiana University where he facilitated the organic teaching laboratories. Prior to joining the chemistry department, Dr. Cooper was a student at Indiana University completing a Bachelor’s of Science in Mathematics and a Bachelor’s of Arts in Chemistry.